BioSeek Inc.

BioSeek Inc. announced that it has entered into a collaboration agreement with Merck KGaA., acting for its division Merck Serono S.A. Under the collaboration, BioSeek will apply its BioMAP(R) Systems to evaluate Merck Serono small molecule compounds and proteins across multiple therapeutic areas in support of target differentiation, lead selection, and nomination of candidates for preclinical development at Merck Serono. BioMAP(R) Systems are primary cell-based models of human disease biology, designed to replicate the intricate cell and pathway interactions as they are observed in vascular inflammation, cardiovascular and respiratory diseases, fibrosis and related clinical indications.